Aferin Beilerli

635 total citations
33 papers, 435 citations indexed

About

Aferin Beilerli is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Aferin Beilerli has authored 33 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Cancer Research and 4 papers in Rheumatology. Recurrent topics in Aferin Beilerli's work include Circular RNAs in diseases (15 papers), Cancer-related molecular mechanisms research (15 papers) and MicroRNA in disease regulation (14 papers). Aferin Beilerli is often cited by papers focused on Circular RNAs in diseases (15 papers), Cancer-related molecular mechanisms research (15 papers) and MicroRNA in disease regulation (14 papers). Aferin Beilerli collaborates with scholars based in Russia, China and Türkiye. Aferin Beilerli's co-authors include Ozal Beylerli, Tatiana Ilyasova, Albert Sufianov, Ilgiz Gareev, Yanchao Liang, В. Н. Павлов, Aamir Ahmad, Guang Yang, Gjumrakch Aliev and Rovshan Khalilov and has published in prestigious journals such as SHILAP Revista de lepidopterología, Current Medicinal Chemistry and Seminars in Cancer Biology.

In The Last Decade

Aferin Beilerli

31 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aferin Beilerli Russia 13 249 202 52 34 27 33 435
Ankit Tiwari India 10 276 1.1× 176 0.9× 43 0.8× 42 1.2× 14 0.5× 29 529
Giuseppe Taurino Italy 12 271 1.1× 125 0.6× 39 0.8× 44 1.3× 26 1.0× 36 521
Cosmin Lisencu Romania 9 219 0.9× 180 0.9× 49 0.9× 36 1.1× 14 0.5× 25 466
Li Tan China 13 259 1.0× 218 1.1× 38 0.7× 43 1.3× 8 0.3× 21 433
Maude Fransolet Belgium 13 246 1.0× 139 0.7× 93 1.8× 47 1.4× 16 0.6× 22 545
Lulu Wang China 13 218 0.9× 111 0.5× 25 0.5× 23 0.7× 12 0.4× 26 458
Xubo Wu China 13 284 1.1× 178 0.9× 32 0.6× 67 2.0× 41 1.5× 30 554
Nsrein Ali Finland 10 285 1.1× 161 0.8× 16 0.3× 44 1.3× 25 0.9× 16 538
Maryam Matbou Riahi Iran 9 215 0.9× 90 0.4× 38 0.7× 59 1.7× 14 0.5× 19 423
Yingying Gong China 15 309 1.2× 164 0.8× 43 0.8× 56 1.6× 8 0.3× 32 522

Countries citing papers authored by Aferin Beilerli

Since Specialization
Citations

This map shows the geographic impact of Aferin Beilerli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aferin Beilerli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aferin Beilerli more than expected).

Fields of papers citing papers by Aferin Beilerli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aferin Beilerli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aferin Beilerli. The network helps show where Aferin Beilerli may publish in the future.

Co-authorship network of co-authors of Aferin Beilerli

This figure shows the co-authorship network connecting the top 25 collaborators of Aferin Beilerli. A scholar is included among the top collaborators of Aferin Beilerli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aferin Beilerli. Aferin Beilerli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zengin, Gökhan, et al.. (2024). Lamiales epidermal dynamics: Unveiling antimicrobial resilience in a structural symphony. Microscopy Research and Technique. 87(9). 2134–2142.
2.
AlNadhari, Saleh, Wahidah H. Al‐Qahtani, Abul Kalam Azad, et al.. (2024). Assessment of the botanical origin of Saudi Arabian honey samples to identify pollen with chromatographic tools and packing and storage. Biomedical Chromatography. 38(7). e5869–e5869. 1 indexed citations
3.
Eftekhari, Aziz, Ozal Beylerli, William C. Cho, et al.. (2024). Recent progresses in natural based therapeutic materials for Alzheimer's disease. Heliyon. 10(4). e26351–e26351. 11 indexed citations
4.
Usman, Muhammad Andry, Aferin Beilerli, Albert Sufianov, et al.. (2023). Investigations into the impact of non-coding RNA on the sensitivity of gastric cancer to radiotherapy. Frontiers in Physiology. 14. 1149821–1149821. 2 indexed citations
5.
Gareev, Ilgiz, Aamir Ahmad, Jiaqi Wang, et al.. (2023). Gastric juice non-coding RNAs as potential biomarkers for gastric cancer. Frontiers in Physiology. 14. 1179582–1179582. 7 indexed citations
6.
Keskin, Cumali, Ayşe Baran, Mehmet Fırat Baran, et al.. (2023). Green synthesis of silver nanoparticles mediated Diospyros kaki L. (Persimmon): determination of chemical composition and evaluation of their antimicrobials and anticancer activities. Frontiers in Chemistry. 11. 1187808–1187808. 25 indexed citations
8.
Zhang, Na, Mehmet Nuri Atalar, Cumali Keskin, et al.. (2023). Antioxidant, AChE inhibitory, and anticancer effects of Verbascum thapsus extract. Cellular and Molecular Biology. 69(14). 211–216. 4 indexed citations
9.
Sufianov, Albert, et al.. (2023). Advances in transdermal siRNAs delivery: A review of current research progress. Non-coding RNA Research. 8(3). 392–400. 14 indexed citations
10.
Gareev, Ilgiz, et al.. (2023). Circular RNAs in intracranial aneurysms: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. Non-coding RNA Research. 9(1). 211–220. 4 indexed citations
11.
Sufianov, Albert, Aferin Beilerli, Tatiana Ilyasova, et al.. (2023). The role of long non-coding RNAs in carbohydrate and fat metabolism in the liver. Non-coding RNA Research. 8(3). 294–301. 5 indexed citations
12.
Beilerli, Aferin, et al.. (2023). Long non-coding RNAs as promising biomarkers and therapeutic targets in cervical cancer. Non-coding RNA Research. 8(2). 233–239. 16 indexed citations
13.
Gareev, Ilgiz, et al.. (2023). The role and clinical relevance of long non-coding RNAs in glioma. Non-coding RNA Research. 8(4). 562–570. 12 indexed citations
14.
Beylerli, Ozal, Jiaming Ju, Aferin Beilerli, et al.. (2023). The roles of long noncoding RNAs in atrial fibrillation. Non-coding RNA Research. 8(4). 542–549. 2 indexed citations
15.
Xu, Jiajun, Mahmut Yıldıztekin, Cumali Keskin, et al.. (2023). Biosynthesis, characterization, and investigation of antimicrobial and cytotoxic activities of silver nanoparticles using Solanum tuberosum peel aqueous extract. Heliyon. 9(8). e19061–e19061. 63 indexed citations
16.
Gilyazova, I. R., Elizaveta Ivanova, Mikhail Y. Sinelnikov, et al.. (2022). The potential of miR-153 as aggressive prostate cancer biomarker. Non-coding RNA Research. 8(1). 53–59. 6 indexed citations
17.
Beilerli, Aferin, et al.. (2022). Therapeutic effect of natural polyphenols against glioblastoma. Frontiers in Cell and Developmental Biology. 10. 1036809–1036809. 18 indexed citations
18.
Beilerli, Aferin, et al.. (2022). Circulating ciRS-7 as a potential non-invasive biomarker for epithelial ovarian cancer: An investigative study. Non-coding RNA Research. 7(3). 197–204. 24 indexed citations
19.
Beilerli, Aferin, Ilgiz Gareev, Ozal Beylerli, et al.. (2021). Circular RNAs as biomarkers and therapeutic targets in cancer. Seminars in Cancer Biology. 83. 242–252. 86 indexed citations
20.
Gareev, Ilgiz, et al.. (2019). Extraction of Exosomes from Glioblastoma Multiforme Patients’ Blood Plasma. SHILAP Revista de lepidopterología. 9(3). 234–238.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026